Home ›
Organizations ›
GATES MEDICAL RESEARCH INSTITUTE
GATES MEDICAL RESEARCH INSTITUTE
MA · Healthcare · EIN 821808476
53
Executives Disclosed
$132.8M
Annual Revenue
$613.2M
Total Assets
2.7:1
Internal Pay Ratio
GATES MEDICAL RESEARCH INSTITUTE has 53 executives with disclosed compensation. The highest-paid executive, Susan Desmond-Hellmann (DIRECTOR), received peak total compensation of $1,529,304. The sector average for Healthcare executives is $506K.
Top Executive Compensation Over Time
Executive Compensation
| Name | Title | Peak Comp. | Latest Comp. | Years | vs. Household |
|---|---|---|---|---|---|
| Susan Desmond-Hellmann | DIRECTOR | $1.5M | $379K | 2017–2020 | 20.4x |
| Trevor Mundel | DIRECTOR, BOARD CHAIR | $1.5M | $1.5M | 2017–2024 | 19.6x |
| Carolyn Ainslie | DIRECTOR | $1.1M | $1.1M | 2021–2024 | 14.8x |
| David Kaufman | HEAD OF TRANSLATIONAL DEVELOPMENT | $997K | $643K | 2018–2019 | 13.3x |
| Michael Dunne | CHIEF MEDICAL OFFICER (END 12/24) | $910K | $910K | 2021–2024 | 12.1x |
| Emilio Emini | CHIEF EXECUTIVE OFFICER (END 6/24) | $900K | $492K | 2017–2024 | 12x |
| Penny Heaton | CEO (END 7/2021) | $875K | $539K | 2017–2021 | 11.7x |
| Helene Madonick | DIRECTOR (END 12/24) | $868K | $0 | 2017–2024 | 11.6x |
| Carolyn Ainslie Start 432020 | DIRECTOR | $843K | $843K | 2020–2020 | 11.2x |
| Harish Kaushal | TREASURER | $807K | $807K | 2023–2024 | 10.8x |
| Debra Weiss | CHIEF OPERATING OFFICER | $773K | $773K | 2018–2024 | 10.3x |
| Toni Hoover | DIRECTOR | $725K | $725K | 2021–2024 | 9.7x |
| Piper Trelstad | HEAD OF CHEM, MANUFAC, & CONTROLS | $678K | $643K | 2023–2024 | 9x |
| Dina Berdieva End 12042020 | HEAD OF PRJ MGMT, CLINICAL OPS | $672K | $672K | 2020–2020 | 9x |
| Jared Silverman | HEAD OF TRANSLATIONAL DISCOVERY | $670K | $670K | 2019–2024 | 8.9x |
| Patrice Matchaba | CHIEF EXECUTIVE OFFICER (START 6/24) | $652K | $652K | 2024–2024 | 8.7x |
| Piper Trelstadstart 1322 | HEAD OF CHEM, MFG, CONTROL | $649K | $649K | 2022–2022 | 8.7x |
| Mahendra Pattni | TREASURER (END 11/28/2023) | $625K | $625K | 2021–2023 | 8.3x |
| Lee Bansil | HEAD OF GLOBAL STRATEGIC COMMUNICATIONS | $622K | $622K | 2022–2022 | 8.3x |
| Charles Wells | HEAD OF THERAPEUTICS DEVELOPMENT | $604K | $604K | 2020–2024 | 8x |
| Alexander Schmidt | HEAD OF DEVELOPMENT | $591K | $591K | 2019–2024 | 7.9x |
| James Huleatt | BIOASSAY DEVELOPMENT LEAD | $583K | $583K | 2023–2023 | 7.8x |
| Marla Curran | HEAD OF BIOSTATISTICS & DATA SCIENCE | $576K | $576K | 2023–2024 | 7.7x |
| Jared Silvermanend 123121 | HEAD OF TRANSLATIONAL DISCOVERY | $575K | $575K | 2022–2022 | 7.7x |
| Monicah Otieno | HEAD OF NONCLINICAL DEVELOP | $571K | $571K | 2020–2020 | 7.6x |
| Gagandeep Kang | DIRECTOR | $570K | $570K | 2023–2024 | 7.6x |
| Claire Wagner | HEAD OF CORP STRAT & MKT ACCESS | $562K | $562K | 2024–2024 | 7.5x |
| Luisa Stamm | CLINICAL DEVELOPMENT LEADER | $550K | $550K | 2023–2023 | 7.3x |
| Antonio Gonzalez Lopez | CLINICAL DEVELOPMENT LEADER | $549K | $549K | 2022–2022 | 7.3x |
| Helen Boudreau End 812019 | SECRETARY & TREASURER | $545K | $545K | 2019–2019 | 7.3x |
| Taryn Rogalski-Salter | HEAD OF GLOBAL REGULATORY STRATEGY | $540K | $400K | 2019–2023 | 7.2x |
| Jeffrey Barret | HEAD OF QUANT. SCIENCES | $533K | $533K | 2019–2019 | 7.1x |
| Mohamed Bassyouni | PRODUCT DEVELOPMENT PROGRAM LEADER | $528K | $528K | 2021–2021 | 7x |
| Sally Jennings | SECRETARY | $525K | $525K | 2018–2024 | 7x |
| Jorg Thommes | HEAD OF CHEM, MFG, CONTROL (END 5/2021) | $522K | $191K | 2019–2021 | 7x |
| Janie Parrino | CLINICAL DEVELOPMENT LEADER | $520K | $520K | 2022–2022 | 6.9x |
| Mary Thistle Start 812019 | TREASURER | $520K | $520K | 2019–2019 | 6.9x |
| Mary Thistle | TREASURER (END 5/2021) | $517K | $293K | 2018–2021 | 6.9x |
| Dina Berdieva | HEAD OF PRJT MGMT, CLINICAL OPS | $513K | $199K | 2018–2021 | 6.8x |
| Russell Weiner | BIOMARKER ASSAY DEVELOPMENT LEADER | $505K | $505K | 2019–2019 | 6.7x |
| David Holtzman | CLINICAL DEVELOPMENT LEADER | $502K | $502K | 2021–2021 | 6.7x |
| Jintanat Ananworanich | CLINICAL DEVELOPMENT LEADER | $492K | $492K | 2020–2020 | 6.6x |
| Sally Jennings Start 812019 | SECRETARY | $491K | $491K | 2019–2019 | 6.6x |
| David Kaufman End 2122020 | HEAD OF TRANSLATIONAL DEVELOPMENT | $489K | $489K | 2020–2020 | 6.5x |
| Jeff Barrett | HEAD OF QUANTITATIVE SCIENCES | $481K | $481K | 2018–2018 | 6.4x |
| Andrew Farnum | DIRECTOR | $473K | $473K | 2019–2019 | 6.3x |
| Yvonne Wolf End 12021 | HEAD OF HUMAN RESOURCES | $407K | $407K | 2021–2021 | 5.4x |
| Jim Bromley | DIRECTOR, SECRETARY AND TREASURER | $373K | $373K | 2017–2017 | 5x |
| Helen Boudreau Start 6112018 | SECRETARY & TREASURER | $336K | $336K | 2018–2018 | 4.5x |
| Jim Bromley End 682018 | DIRECTOR, SECRETARY & TREASURER | $308K | $308K | 2018–2018 | 4.1x |
| Andrew Farnum Start 5222018 | DIRECTOR | $266K | $266K | 2018–2018 | 3.5x |
| Andrew Farnum End 432020 | DIRECTOR | $141K | $0 | 2020–2020 | 1.9x |
| Mary Thistle End 42922 | FORMER TREASURER, CHIEF OF STAFF | $97K | $97K | 2022–2022 | 1.3x |
Annual Summary
| Year | Executives | Avg. Comp. | Highest Comp. | Total Payroll |
|---|---|---|---|---|
| 2017 | 6 | $529K | $884K | $3.2M |
| 2018 | 14 | $656K | $1.5M | $9.2M |
| 2019 | 18 | $652K | $1.5M | $11.7M |
| 2020 | 19 | $611K | $1.2M | $11.0M |
| 2021 | 20 | $554K | $1.2M | $10.5M |
| 2022 | 18 | $644K | $1.3M | $10.9M |
| 2023 | 19 | $660K | $1.4M | $11.9M |
| 2024 | 17 | $730K | $1.5M | $11.7M |
Email Alerts
Get notified about GATES MEDICAL RESEARCH INSTITUTE
Get an email when a new IRS Form 990 filing is posted that includes this organization. We send a confirmation link first - we don't add you to any other list.